MediWound (MDWD)
(Delayed Data from NSDQ)
$17.70 USD
+1.35 (8.26%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $17.73 +0.03 (0.17%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$17.70 USD
+1.35 (8.26%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $17.73 +0.03 (0.17%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Zacks News
Will MediWound (MDWD) Report Negative Q2 Earnings? What You Should Know
by Zacks Equity Research
MediWound (MDWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bear of the Day: Vericel (VCEL)
by Kevin Cook
Restoring cartilage in sports medicine and rebuilding skin after severe burns gave this small-cap big upside
MediWound (MDWD) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
MediWound (MDWD) delivered earnings and revenue surprises of 16.67% and 10.32%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate MediWound (MDWD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
MediWound (MDWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
MediWound (MDWD) delivered earnings and revenue surprises of 45.45% and 19.48%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
MediWound (MDWD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
MediWound (MDWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MediWound (MDWD) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
MediWound (MDWD) delivered earnings and revenue surprises of 0.00% and 2.16%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Will MediWound (MDWD) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
MediWound (MDWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MediWound (MDWD) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
MediWound (MDWD) delivered earnings and revenue surprises of 0.00% and -15.84%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
MediWound (MDWD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
MediWound (MDWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MediWound (MDWD) Jumps: Stock Rises 9.4%
by Zacks Equity Research
MediWound (MDWD) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Zacks.com featured highlights include: MediWound, Issuer Direct, BWX Technologies and Teekay Tankers
by Zacks Equity Research
Zacks.com featured highlights include: MediWound, Issuer Direct, BWX Technologies and Teekay Tankers
4 Profitable Stocks to Boost Returns Using Net Income Ratio
by Nitish Marwah
Investors always look for companies with a high level of profitability regardless of the present market condition.
MediWound (MDWD) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
MediWound (MDWD) delivered earnings and revenue surprises of 35.71% and 4.42%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
MediWound (MDWD) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
by Zacks Equity Research
MediWound (MDWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
MediWound (MDWD) delivered earnings and revenue surprises of -8.33% and 32.86%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
MediWound (MDWD) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
MediWound (MDWD) delivered earnings and revenue surprises of 15.38% and 92.80%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: MediWound (MDWD) Q3 Earnings Expected to Decline
by Zacks Equity Research
MediWound (MDWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate MediWound (MDWD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
MediWound (MDWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MediWound (MDWD) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
MediWound (MDWD) delivered earnings and revenue surprises of 20.00% and 194.98%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Will MediWound (MDWD) Report Negative Q2 Earnings? What You Should Know
by Zacks Equity Research
MediWound (MDWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
MediWound (MDWD) delivered earnings and revenue surprises of -7.14% and -23.17%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Will MediWound (MDWD) Report Negative Q1 Earnings? What You Should Know
by Zacks Equity Research
MediWound (MDWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: MediWound (MDWD) Q4 Earnings Expected to Decline
by Zacks Equity Research
MediWound (MDWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Small Drug Stocks Near-Term Outlook Positive, Despite Headwinds
by Zacks Equity Research
Small drugmakers, in general, are having a decent year, despite failures of key pipeline candidates in pivotal studies.